Abstract
The knowledge about conformation of proteins and distinct interactions between a ligand and it’s target protein is necessary to explain pharmacological data on a molecular level. Additionally, based on this knowledge, it may be possible to develop new, potent drugs more efficiently. But how get these insights on a molecular level? Several experimental techniques, like mutagenesis studies combined with pharmacological investigations may give hints about amino acids, being important for stability of a protein or being important for the interaction between ligand and protein. But these studies exhibit no information about energetics and hydrogenbond- networking for example. Other techniques, like determination of structures of proteins or protein-ligand-complexes by NMR or crystallography are very useful to obtain information about secondary, tertiary or quartary structures of proteins (http://www.pdb.org).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Strasser, A., Wittmann, HJ. (2013). Introduction. In: Modelling of GPCRs. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4596-4_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-4596-4_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4595-7
Online ISBN: 978-94-007-4596-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)